Sozinibercept (Anti-VEGF-C/-D) Combined with Ranibizumab for Polypoidal Choroidal Vasculopathy: Phase IIb Predefined Subgroup Analysis

Purpose: The aim of this study was to assess the efficacy of sozinibercept, a novel “trap” inhibitor of VEGF-C and VEGF-D, when combined with ranibizumab for the treatment of polypoidal choroidal vasculopathy (PCV). Design: Prespecified subgroup analysis of a randomized, double-masked, sham-controll...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Chui Ming Gemmy Cheung, MD, FRCOphth, Timothy L. Jackson, PhD, FRCOphth, Charles C. Wykoff, MD, PhD, Arshad M. Khanani, MD, FASRS, Ian M. Leitch, PhD, Megan E. Baldwin, PhD, Jason Slakter, MD
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2025-07-01
coleção:	Ophthalmology Science
Assuntos:	Neovascular age-related macular degeneration Polypoidal choroidal vasculopathy Sozinibercept VEGF-C/-D
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S2666914525000570
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!